Harvard Bioscience (HBIO) EBIT Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 30.74% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -10.28% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -95.55% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -1.28% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -38.47% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 16.53% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -15.42% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -116.77% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 13.61% |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -19.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.41% |
| Mar 31, 2026 | 97.64% |
| Dec 31, 2025 | 15,445.45% |
| Sep 30, 2025 | 110.51% |
| Jun 30, 2025 | 60.42% |
| Mar 31, 2025 | -2,079.38% |
| Dec 31, 2024 | -96.10% |
| Sep 30, 2024 | -100.86% |
| Jun 30, 2024 | -359.92% |
| Mar 31, 2024 | -230.30% |
| Dec 31, 2023 | 161.71% |
| Sep 30, 2023 | 75.20% |
| Jun 30, 2023 | -80.09% |
| Mar 31, 2023 | 126.06% |
| Dec 31, 2022 | -126.90% |
| Sep 30, 2022 | -786.50% |
| Jun 30, 2022 | 6,793.10% |
| Mar 31, 2022 | -2,708.37% |
| Dec 31, 2021 | -38.35% |
| Sep 30, 2021 | 201.10% |